ORKA vs PTGX Stock Comparison

ORKA currently leads PTGX in this stock comparison, with AIQ scores of 77 vs 73. The clearest difference is momentum, while PTGX has the stronger risk resilience profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 4 points
ORKA
Healthcare
vs
PTGX
Healthcare
ORKA
Oruka Therapeutics, Inc.
Leads
Price
$105
Day move
+0.34%
AIQ Score
77/100
Best edge
Momentum
Sector
Healthcare
PTGX
Protagonist Therapeutics, Inc.
Price
$131
Day move
-2.55%
AIQ Score
73/100
Best edge
Risk Resilience
Sector
Healthcare

What is the main difference between ORKA and PTGX?

ORKA leads the current stock comparison as Oruka Therapeutics, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Oruka Therapeutics, Inc. vs Protagonist Therapeutics, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 63/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 3/10

ORKA leads

ORKA leads by 4 AIQ points, primarily on Momentum, having only recently taken the lead back from PTGX. Wall Street currently favors PTGX on target upside.

Fragile: 2 of 5 evidence groups support ORKA, the lead recently changed hands, and its current signal state is conflicted.

Evidence agreement: 2 of 5Comparison trend: Reversed
ORKA

Oruka Therapeutics, Inc.

Leads
AIQ Score
77/100
AIQ Edge Score
10/10
PTGX

Protagonist Therapeutics, Inc.

AIQ Score
73/100
AIQ Edge Score
9/10

The Algovestiq AIQ Score currently favors ORKA over PTGX, 77 versus 73 as of Nov 15, 2026. ORKA's advantage is driven primarily by stronger momentum, while PTGX holds the stronger risk resilience profile. ORKA also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors PTGX. 2 of 5 covered evidence groups favor ORKA today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 4 points. ORKA lead: Reversed — PTGX led by 8 AIQ points 30 sessions ago; ORKA now leads by 4.

Compare Oruka Therapeutics, Inc. and Protagonist Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

ORKA
+313.1%
PTGX
+216.2%

Total return comparison

Growth of $10,000, distributions reinvested

ORKA $41,314 · PTGX $31,623

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare ORKA and PTGX against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

ORKA advantage
0
PTGX advantage
  • Risk Resilience53 vs 70
    PTGX +17
  • Momentum81 vs 70
    ORKA +11
  • Quality83 vs 81
    Even

2 of 5 evidence groups favor ORKA. ORKA’s edge is concentrated in momentum; PTGX keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

ORKA+1 AIQ

Largest factor move: Momentum +2

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.68x)
PTGX-2 AIQ

Largest factor move: Momentum -3

New signals

  • Accumulation Pattern — bullish, volume, medium horizon (1.25x)

ORKA's lead widened by 3 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — ORKA and PTGX both carry a full feed there.

The central trade-off

ORKA (Oruka Therapeutics, Inc.): the stronger current systematic profile, led by momentum.

PTGX (Protagonist Therapeutics, Inc.): the counter-case, on risk resilience, fundamentals, analyst expectations.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

ORKA

ORKA on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

PTGX

PTGX on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

ORKA

ORKA on the Momentum factor, by 11 points.

Lower downside

PTGX

PTGX on Risk Resilience, by 17 points.

Analyst upside

PTGX

PTGX on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors ORKA, analyst targets favor PTGX. That disagreement is the most useful thing on this page.

MeasureORKAPTGXNote
Implied upside to target+9.2%+35%PTGX has more room
Target dispersion+13%+17%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1314Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

2 of 5 covered evidence groups favor ORKA. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreORKA77 vs 73
FundamentalsPTGXEPS growth 4.5% vs 34.4%; TTM ROE -4.2% vs 20.3%
ValuationNot coveredNot covered
TechnicalsORKAPrice vs 50-day 17.5% vs -6.7%; vs 200-day 45% vs 9.8%
Risk ResiliencePTGXRisk Resilience 53 vs 70
Analyst expectationsPTGXTarget upside 9.2% vs 35%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ORKA and PTGX and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 4 points. (argues the conclusion is provisional)
  • Only 2 of 5 covered evidence groups agree. (argues the conclusion is provisional)
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ORKA.

How the comparison changed

45 daily snapshots · Sep 14 – Nov 13

ORKA lead: Reversed — PTGX led by 8 AIQ points 30 sessions ago; ORKA now leads by 4.

Sep 14ORKA leads above the line · PTGX leads belowNov 13
Today
ORKA +4
77 vs 73
7 sessions ago
Level
76 vs 76
30 sessions ago
PTGX +8
68 vs 76
90 sessions ago
Not covered

The lead changed hands once in this window, most recently on Sep 25 when PTGX moved ahead of ORKA.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

ORKAConflicted

4 bullish / 1 bearish / 1 neutral, conflicted

Only ORKA

  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.68x)
  • TRIX Bullish Signal — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon
PTGXConflicted

3 bullish / 1 bearish / 1 neutral, conflicted

Only PTGX

  • Accumulation Pattern — bullish, volume, medium horizon (1.25x)
  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-16.8%)
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon

Both carry 2 more signals that do not separate them: Golden Cross Active, ATR Expansion - Breakout Mode.

ORKA leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

ORKAConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +0.34%, AIQ +1 points).

PTGXConfirmed weakness

Price and the AIQ Score both moved down over the latest session (price -2.55%, AIQ -2 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1PTGX closes the Momentum gap — currently 11 points behind, the largest single contributor to ORKA's edge.
  2. 2PTGX generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover or EMA Ribbon Expansion Bullish.
  3. 3ORKA's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

PTGX leads on balance
MetricORKAPTGX
Revenue growth (YoY)0%28.5%
EPS growth (YoY)4.5%34.4%
Gross margin0%99.7%
Operating margin0%58.6%
Return on equity (TTM)-4.2%20.3%
Debt to equity00.01

Performance

ORKA leads 6 of 6 windows
MetricORKAPTGX
1 week (5 sessions)2.4%-0.8%
1 month (20 sessions)46.5%1.7%
3 months (63 sessions)-6.5%-17.4%
6 months (126 sessions)70.1%28.2%
Year to date247.6%49.9%
1 year (252 sessions)272.3%54.3%

Technicals

ORKA has the stronger structure
MetricORKAPTGX
RSI (14)64.438.9
ADX (14)35.219.7
Price vs 50-day17.5%-6.7%
Price vs 200-day45%9.8%
Volatility (1M, annualized)64.3%37.7%

Risk

PTGX is the more resilient
MetricORKAPTGX
Beta1.40.91
Sharpe ratio2.291.24
Sortino ratio4.31.95
Max drawdown-36.4%-18.8%
Current drawdown-6.8%-17.4%
Annualized volatility69.1%40.1%
Value at risk (95%)-5.3%-3.7%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, ORKA or PTGX?

On the Algovestiq AIQ Score, ORKA is the stronger of the two as of Nov 15, 2026, scoring 77 against PTGX's 73. The edge comes from momentum. PTGX is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is ORKA or PTGX the better buy right now?

ORKA carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 2 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 4 points. Treat the lead as provisional.

Why does the AIQ Score favor ORKA over PTGX?

The composite weights Quality, Value, Momentum and Risk Resilience. PTGX leads Risk Resilience by 17 points; ORKA leads Momentum by 11 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, ORKA or PTGX?

Analyst price targets imply +9.2% upside for ORKA and +35% for PTGX, so the Street currently favors PTGX. That points the opposite way to the AIQ Score, which favors ORKA. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, ORKA or PTGX?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, ORKA or PTGX?

PTGX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, ORKA or PTGX?

ORKA on the Momentum factor, by 11 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, ORKA or PTGX?

PTGX is the more resilient of the two, so the other name carries the higher downside risk. PTGX on Risk Resilience, by 17 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is ORKA more profitable than PTGX?

PTGX leads on the comparable margin measures — gross margin 0% vs 99.7%; operating margin 0% vs 58.6%; ttm roe -4.2% vs 20.3%.

Is ORKA's lead over PTGX getting stronger or weaker?

ORKA lead: Reversed — PTGX led by 8 AIQ points 30 sessions ago; ORKA now leads by 4. This is measured from 45 daily comparison snapshots between 2026-09-14 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-09-25, when PTGX moved ahead of ORKA.

What would change the ORKA vs PTGX verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: PTGX closes the Momentum gap — currently 11 points behind, the largest single contributor to ORKA's edge; PTGX generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover or EMA Ribbon Expansion Bullish; ORKA's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about ORKA and PTGX?

ORKA: 4 bullish / 1 bearish / 1 neutral, conflicted. PTGX: 3 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ORKA is Golden Cross Active (bullish, long horizon). On PTGX it is Golden Cross Active (bullish, long horizon).

Compare ORKA and PTGX with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.